Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Seven Year Followup for Bystander Vaccine Therapy in Mantle Cell Lymphoma (MCL)

Bijal D. Shah, MD, Jianguo Tao, MD PhD, Paul A. Chervenick, MD, Marcie L Riches, MD MS, Javier Pinilla-Ibarz, MD PhD, Lynn C. Moscinski, MD, Scott Antonia, MD, Eduardo M. Sotomayor, MD, Sophie Dessureault, MD

Blood (2014) 124 (21): 3083.

https://doi.org/10.1182/blood.V124.21.3083.3083

Published: 2014

Journal Articles

Long Term Followup of Bystander Vaccine Therapy in Mantle Cell Lymphoma (MCL),

Bijal D. Shah, MD, Jianguo Tao, MD, PhD, Lubomir Sokol, MD, PhD, Paul A. Chervenick, MD, Marcie Tomblyn, MD, MS, Javier Pinilla-Ibarz, MD, PhD, Lynn Moscinski, MD, Scott Antonia, MD, Eduardo M. Sotomayor, Sophie Dessureault, MD

Blood (2011) 118 (21): 3720.

https://doi.org/10.1182/blood.V118.21.3720.3720

Published: 2011

Journal Articles

Enhanced Immunological Responses Following K562/GM-CSF/CD40L Vaccine Plus Lenalidomide in High-Risk Myelodysplastic Syndrome

John Powers, B.S., Eric Padron, MD, Jason Dubovsky, Ph.D, Emmanuel Berchmans, B.S., Tyler Farnum, Fanqi Bai, MD, Eva Sahakian, Ph.D, Jamil Ahmed, Rami S. Komrokji, MD, Jeffrey E. Lancet, MD, Alan F. List, MD, Douglas G McNeel, MD, Sophie Dessureault, MD, Scott Antonia, MD, Eduardo M. Sotomayor, P.K. Epling-Burnette, PharmD, PhD, Javier Pinilla-Ibarz, MD, PhD

Blood (2011) 118 (21): 1725.

https://doi.org/10.1182/blood.V118.21.1725.1725

Published: 2011

Journal Articles

MiR-29 MicroRNAs Regulate IGF-1R Expression and Contribute Mantle Cell Lymphoma Growth and Survival.

Jianhong Lin, MD, Jianjun Zhao, MD, Tint Lwin, MD, PhD, Crespo Luis, BS, Fangxia Guan, MD, Sophie Dessureault, MD, PhD, Lynn C. Moscinski, MD, William S. Dalton, PhD, MD, Eduardo M. Sotomayor, MD, Jin Cheng, Jianguo Tao, MD, PhD

Blood (2009) 114 (22): 1957.

https://doi.org/10.1182/blood.V114.22.1957.1957

Published: 2009

Journal Articles

Use of MicroRNA Expression Profiling to Identify Prognostic Subclasses in Mantle Cell Lymphoma: Mir-29 Family as New Prognostic Markers

Jianhong Lin, MD, Jianjun Zhao, MD, PhD, Tint Lwin, MD, PhD, Sophie Dessureault, MD, PhD, Lynn C. Moscinski, MD, William S. Dalton, MD, PhD, Eduardo Sotomayor, MD, Jin Cheng, MD, PhD, Jianguo Tao, MD, PhD

Blood (2008) 112 (11): 3744.

https://doi.org/10.1182/blood.V112.11.3744.3744

Published: 2008

Journal Articles

Analysis of T-Cell Subpopulations in the Lymph Nodes of Patients with Mantle Cell Lymphoma.

Elizabeth Sagatys, MD, Lynn Moscinski, MD, Sophie Dessureault, MD, Eduardo Sotomayor, MD, Hernani Cualing, MD

Blood (2007) 110 (11): 1580.

https://doi.org/10.1182/blood.V110.11.1580.1580

Published: 2007

Journal Articles

Bystander-Based Immunotherapy for Patients with Mantle Cell Lymphoma (MCL): Proof of Principle.

Sophie Dessureault, MD, PhD, David Noyes, BSc, Jianguo Tao, MD, Lynn Moscinski, MD, Michael Schell, PhD, Scott J. Antonia, MD, PhD, Eduardo M. Sotomayor, MD

Blood (2007) 110 (11): 4483.

https://doi.org/10.1182/blood.V110.11.4483.4483

Published: 2007

NARROW

Seven Year Followup for Bystander Vaccine Therapy in Mantle Cell Lymphoma (MCL)

Long Term Followup of Bystander Vaccine Therapy in Mantle Cell Lymphoma (MCL),

Enhanced Immunological Responses Following K562/GM-CSF/CD40L Vaccine Plus Lenalidomide in High-Risk Myelodysplastic Syndrome

MiR-29 MicroRNAs Regulate IGF-1R Expression and Contribute Mantle Cell Lymphoma Growth and Survival.

Use of MicroRNA Expression Profiling to Identify Prognostic Subclasses in Mantle Cell Lymphoma: Mir-29 Family as New Prognostic Markers

Analysis of T-Cell Subpopulations in the Lymph Nodes of Patients with Mantle Cell Lymphoma.

Bystander-Based Immunotherapy for Patients with Mantle Cell Lymphoma (MCL): Proof of Principle.

Email alerts

ASH Publications

American Society of Hematology

Seven Year Followup for Bystander Vaccine Therapy in Mantle Cell Lymphoma (MCL)

Long Term Followup of Bystander Vaccine Therapy in Mantle Cell Lymphoma (MCL),

Enhanced Immunological Responses Following K562/GM-CSF/CD40L Vaccine Plus Lenalidomide in High-Risk Myelodysplastic Syndrome

MiR-29 MicroRNAs Regulate IGF-1R Expression and Contribute Mantle Cell Lymphoma Growth and Survival.

Use of MicroRNA Expression Profiling to Identify Prognostic Subclasses in Mantle Cell Lymphoma: Mir-29 Family as New Prognostic Markers

Analysis of T-Cell Subpopulations in the Lymph Nodes of Patients with Mantle Cell Lymphoma.

Bystander-Based Immunotherapy for Patients with Mantle Cell Lymphoma (MCL): Proof of Principle.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only